Home
Scholarly Works
Beyond metabolites: A wearable biointerface...
Journal article

Beyond metabolites: A wearable biointerface integrating antibody and aptamer probes for the real-time tracking of proteins in vivo

Abstract

Continuous monitoring of protein biomarkers could transform the management of acute and chronic diseases. Despite tremendous potential, wearable health monitors have remained largely limited to metabolites and small molecules. A key challenge is the limited availability of biointerfaces that reversibly track low-abundance proteins in vivo without user intervention. Here, we present the Differential Aptalyzer, a minimally invasive hydrogel microneedle platform for continuous monitoring of proteins in skin interstitial fluid. The platform combines high-affinity antibodies for selective target capture with aptamers for reversible electrochemical signal transduction. When integrated into a differential electrochemical chip and pulse-assisted sensor regeneration, this approach enables continuous monitoring of proteins in a wearable format. Using cardiac troponin I (cTnI) as a clinically relevant model analyte, Differential Aptalyzer offers a broad dynamic range (0.003 to 0.640 nanograms per milliliter) and strong specificity against interfering proteins. This platform reliably tracks both rising and falling exogenous cTnI levels injected into healthy mice, as well as endogenously elevated cTnI in a double-knockout mouse model of coronary artery disease, demonstrating its capability in continuous protein monitoring and identifying coronary artery disease cohorts.

Authors

Zheng H; Shafique F; Qian AS; Garg M; Gessler F; L’Heureux Hache J; Quach QM; Trigatti BL; Poudineh M; Soleymani L

Journal

Science Advances, Vol. 12, No. 47,

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

November 20, 2026

DOI

10.1126/sciadv.aej0899